Emerging concepts in neuropathic and neurogenic itch

被引:13
作者
Auyeung, Kelsey L. [1 ]
Kim, Brian S. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Mark Lebwohl Ctr Neuroinflammat & Sensat, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Marc & Jennifer Lipschultz Precis Immunol Inst, New York, NY USA
[4] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA
[5] Icahn Med Inst, 1425 Madison Ave,Room L12-75A, New York, NY 10029 USA
关键词
ATOPIC-DERMATITIS; DOUBLE-BLIND; PRURIGO NODULARIS; MAST-CELL; PLACEBO; ADOLESCENTS; NEMOLIZUMAB; SENSATION; DUPILUMAB; INSIGHTS;
D O I
10.1016/j.anai.2023.08.008
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Chronic pruritus has multiple etiologies, ranging from inflammatory to metabolic and neuropathic processes. However, recent advances in itch biology have shed light on potential mechanisms that explain the molecular and cellular basis of these pathologies. Furthermore, new understanding of neuroimmune itch circuits necessi-tates clarification of terminologies such as "neuropathic" and "neurogenic." This review provides an overview of ways new concepts may better explain the pathophysiology of a variety of chronic pruritic disorders and the rationale for directing emerging novel therapeutic strategies toward them. (c) 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. This is an open access arti-cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:561 / 566
页数:6
相关论文
共 62 条
[1]   Pruritus in Elderly Patients-Eruptions of Senescence [J].
Berger, Timothy G. ;
Steinhoff, Martin .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2011, 30 (02) :113-117
[2]  
Bernhard Jeffrey D, 2005, Dermatol Ther, V18, P288, DOI 10.1111/j.1529-8019.2005.00040.x
[3]   Mechanisms of pruritus in cholestasis: understanding and treating the itch [J].
Beuers, Ulrich ;
Wolters, Frank ;
Elferink, Ronald P. J. Oude .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (01) :26-36
[4]   A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1 [J].
Cevikbas, Ferda ;
Wang, Xidao ;
Akiyama, Tasuku ;
Kempkes, Cordula ;
Savinko, Terhi ;
Antal, Attila ;
Kukova, Gabriela ;
Buhl, Timo ;
Ikoma, Akihiko ;
Buddenkotte, Joerg ;
Soumelis, Vassili ;
Feld, Micha ;
Alenius, Harri ;
Dillon, Stacey R. ;
Carstens, Earl ;
Homey, Bernhard ;
Basbaum, Allan ;
Steinhoff, Martin .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) :448-+
[5]   Transcriptional profiling at whole population and single cell levels reveals somatosensory neuron molecular diversity [J].
Chiu, Isaac M. ;
Barrett, Lee B. ;
Williams, Erika ;
Strochlic, David E. ;
Lee, Seungkyu ;
Weyer, Andy D. ;
Lou, Shan ;
Bryman, Gregory ;
Roberson, David P. ;
Ghasemlou, Nader ;
Piccoli, Cara ;
Ahat, Ezgi ;
Wang, Victor ;
Cobos, Enrique J. ;
Stucky, Cheryl L. ;
Ma, Qiufu ;
Liberles, Stephen D. ;
Woolf, Clifford J. .
ELIFE, 2014, 3
[6]   Skin neurogenic inflammation [J].
Choi, Jae Eun ;
Di Nardo, Anna .
SEMINARS IN IMMUNOPATHOLOGY, 2018, 40 (03) :249-259
[7]   Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [J].
Dillon, SR ;
Sprecher, C ;
Hammond, A ;
Bilsborough, J ;
Rosenfeld-Franklin, M ;
Presnell, SR ;
Haugen, HS ;
Maurer, M ;
Harder, B ;
Johnston, J ;
Bort, S ;
Mudri, S ;
Kuijper, JL ;
Bukowski, T ;
Shea, P ;
Dong, DL ;
Dasovich, M ;
Grant, FJ ;
Lockwood, L ;
Levin, SD ;
LeCiel, C ;
Waggie, K ;
Day, H ;
Topouzis, S ;
Kramer, J ;
Kuestner, R ;
Chen, Z ;
Foster, D ;
Parrish-Novak, J ;
Gross, JA .
NATURE IMMUNOLOGY, 2004, 5 (07) :752-760
[8]   Peripheral and Central Mechanisms of Itch [J].
Dong, Xintong ;
Dong, Xinzhong .
NEURON, 2018, 98 (03) :482-494
[9]   Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications [J].
Elmariah, Sarina ;
Chisolm, Sarah ;
Sciascia, Thomas ;
Kwatra, Shawn G. .
JAAD INTERNATIONAL, 2022, 7 :156-163
[10]  
Galderma. R&D, An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis